Treatment of intrabony defects with beta-tricalciumphosphate alone and in combination with platelet-rich plasma
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, sa.4, ss.976-983, 2012 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Basım Tarihi: 2012
- Doi Numarası: 10.1002/jbm.b.32660
- Dergi Adı: JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.976-983
- Anahtar Kelimeler: randomized controlled clinical trials, therapy, intrabony defects, beta-tricalcium phosphate, platelet-rich plasma, chronic periodontitis, GUIDED TISSUE REGENERATION, BONE-FORMATION, PERIODONTAL REPAIR, CLINICAL-TRIAL, GROWTH-FACTORS, PHOSPHATE, ALLOGRAFTS, THERAPY, GRAFTS, HUMANS
- Gazi Üniversitesi Adresli: Evet
Özet
Background: The therapeutic efficacy of platelet-rich plasma (PRP) still remains controversial. This study aimed to compare the efficacy of a beta-tricalcium phosphate (beta-TCP) and PRP/beta-TCP combination both clinically and radiographically.